Colgate-Palmolive (NYSE:CL) Shares Bought by Soltis Investment Advisors LLC

Soltis Investment Advisors LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 374.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,745 shares of the company's stock after buying an additional 8,480 shares during the quarter. Soltis Investment Advisors LLC's holdings in Colgate-Palmolive were worth $977,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. FMR LLC grew its holdings in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. Barclays PLC grew its holdings in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. State Street Corp grew its holdings in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB grew its holdings in Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock worth $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its holdings in Colgate-Palmolive by 864.1% in the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company's stock worth $80,749,000 after purchasing an additional 697,168 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL stock traded down $1.66 on Friday, reaching $86.10. 4,136,566 shares of the company were exchanged, compared to its average volume of 4,998,359. The company has a market cap of $70.34 billion, a price-to-earnings ratio of 24.46, a P/E/G ratio of 4.12 and a beta of 0.44. The business has a 50-day moving average price of $89.69 and a 200 day moving average price of $96.48. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. Colgate-Palmolive has a 1 year low of $83.20 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. Equities research analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Analyst Ratings Changes

Several research firms have issued reports on CL. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Finally, TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.